| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235903 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 5 Pages |
Abstract
Our results have demonstrated that low-dose involved-field radiotherapy induces a high response rate in both CBCL and cutaneous T-cell lymphoma lesions without any toxicity. Therefore, this treatment is now our standard palliative treatment. At progression, it is safe and feasible to apply greater radiation doses.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Karen J. M.D., Ph.D., Erik C. M.D., Maarten H. M.D., Ph.D., Nancy J. M.D., Rein M.D., Ph.D., Evert M. M.D., Ph.D.,